Natural history studies are vital for understanding disease progression, particularly in rare diseases. They provide a baseline to evaluate the effectiveness of...
Continue reading
Precision medicine takes into account individual differences in patients' genes, environments, and lifestyles to guide treatment and prevention. That reliance o...
Continue reading
Last week, our team had the opportunity to attend the World Orphan Drug Congress in Boston. The event was a dynamic gathering, where leaders from biopharma, reg...
Continue reading
Children born with rare inherited conditions often face a protracted diagnostic odyssey before the cause of their illness is identified. This delay is costly, s...
Continue reading
In the informative webinar hosted by Dr. Patrick Short, Co-founder and CEO of Sano Genetics, guest Dr. Andrea Gropman explored the profound impact of genetics a...
Continue reading
Last week, Sano had the privilege of travelling to Boston for the Chief Medical Officer Summit 360°, where our Co-founder and COO, Charlotte Guzzo, shared her e...
Continue reading
Natural history studies are instrumental in advancing precision medicine by offering a nuanced understanding of the patient journey across various diseases, inc...
Continue reading
This webinar, co-hosted by Sano Genetics and PrecisionLife, highlighted the complex nature of long Covid, which affects up to 30% of Covid-19 survivors and pres...
Continue reading
Liver disease remains one of the leading causes of morbidity and mortality worldwide, presenting complex challenges in healthcare due to its multifaceted nature...
Continue reading
Personalized medicine depends on the characterization of individuals' phenotypes and genotypes, including molecular profiling, medical imaging, and lifestyle da...
Continue reading